Press releases

Month Year

Email alerts

Nov 5, 2013

Medtronic Announces FDA Approval to Enroll First U.S. Renal Denervation Clinical Study for Patients with Moderate Uncontrolled Hypertension

Thomson Reuters ONE via COMTEX) --SYMPLICITY HTN-4 Will Potentially Expand Access for Additional Patients at Risk for Cardiovascular Complications Related to Uncontrolled Hypertension MINNEAPOLIS...
Oct 31, 2013

In Studies of Medtronic Stents, Patients Who Interrupted Dual Antiplatelet Therapy Early Saw No Increased Thrombosis Risk

(Thomson Reuters ONE via COMTEX) --New Data Presented at TCT and Published by JAMA Affirms Excellent Safety Profile of Zotarolimus-Eluting Stents SAN FRANCISCO -- Oct. 31, 2013 -- According to...
Oct 31, 2013

In Trial of Rivals, Medtronic's Resolute Integrity Stent Outperforms Promus Element Stent on Longitudinal Strength

(Thomson Reuters ONE via COMTEX) --Presented at TCT and Published by The Lancet, Results of DUTCH PEERS Negate Notion of Class Effect with Structural Stability of 'More Flexible and Highly...
Oct 30, 2013

Medtronic Presents Three-Year Results From SYMPLICITY HTN-2 Showing Significant and Sustained Drops in Blood Pressure After Treatment with the Symplicity(TM) Renal Denervation System

Thomson Reuters ONE via COMTEX) --Longest-term data from the first randomized, controlled trial of renal denervation presented at the 25th Annual Transcatheter Cardiovascular Therapeutics (TCT)...
Oct 30, 2013

Thomson Reuters ONE via COMTEX) --First Rigorous Prospective Analysis of Extreme Risk Patients Presented at TCT13 SAN FRANCISCO and MINNEAPOLIS - Oct. 30, 2013 - Following the first U.S. data...

Show per page